Samsung Biologics signed a 92.7 billion won CMO contract with MSD

Reporter Kim Jisun / approved : 2024-03-13 03:58:11
  • -
  • +
  • 인쇄

Samsung Biologics. (Photo = Samsung Biologics)

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] Samsung BioLogics said in a public announcement on the 12th that it has signed a KRW 92.7 billion consignment production contract with global pharmaceutical company MSD Switzerland. This is equivalent to 3.09% of sales as of 2022.

The contract period can be changed according to the agreement between the two companies until December 31, 2032.

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Eastar Jet Founder Lee Sang-jik Acquitted in Hiring Irregularities Case on Appeal2025.11.06
SK & AWS Ulsan AI Data Center Plan Faces Delay as Ulsan Mipo Industrial Complex Excluded from Korea’s Distributed Energy Special Zone2025.11.06
Seoul High Prosecutors’ Office Launches Search of Ssangbangwool Group Subsidiary Amid Allegations of “Salmon & Soju Party” Witness Bribery in North-Korea Remittance Probe2025.11.06
National Pension Service of Korea to Support Elon Musk’s Compensation Package at Tesla; Opposes AI-Startup Investment Proposal2025.11.06
Hyundai Rotem Refutes Allegations of Supplying Faulty Locomotive Parts to Bangladesh2025.11.06
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사